These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8197755)

  • 21. [Study results of routine clinical practice. Do rheumatism patients get substandard care?].
    MMW Fortschr Med; 2005 Nov; 147(47):63. PubMed ID: 16370199
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tolerance of ibuprofen. Controlled drug monitoring for the detection of rare side effects].
    Billigmann PW
    Fortschr Med; 1991 Mar; 109(9):213-6. PubMed ID: 2060895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
    Huang SC; Miki K; Furihata C; Ichinose M; Shimizu A; Oka H
    Clin Chim Acta; 1988 Jun; 175(1):37-50. PubMed ID: 3168282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.
    Santhosh S; Anandan R; Sini TK; Mathew PT
    J Gastroenterol Hepatol; 2007 Jun; 22(6):949-53. PubMed ID: 17504261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ibuprofen--successful in activated arthrosis. Results of a administration study].
    Lewandowski C; Hilken K; Seifert F; Rollinger Y; Vögtle-Junkert U
    Fortschr Med; 1992 Dec; 110(34):651-4. PubMed ID: 1483619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy and gastric tolerance of ibuprofen (Brufen) at 1600-2400 mg dosage in rheumatoid arthritis.
    Porkodi R; Raghuram K; Parthiban M; Chandrasekaran AN
    Br J Clin Pract; 1987 Dec; 41(12):1037-40. PubMed ID: 3504321
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of antirheumatic drug-induced ulcer in comparison with peptic gastroduodenal ulcer. Five-year analysis of a hospital patient sample].
    Benz J; Wiedbrauck F; Hotz J
    Med Klin (Munich); 1993 Aug; 88(8):463-70. PubMed ID: 8413047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experiences with 800 mg ibuprofen retard in ambulatory patients with activated osteoarthrosis and extra-articular rheumatic manifestations].
    Adam W
    Z Rheumatol; 1991; 50 Suppl 1():69-76. PubMed ID: 1858446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site of peptic ulcer. comparison of hydrochloric acid output, pepsinogen and gastrin serum levels.
    Engler-Pinto Júnior P; Gama-Rodrigues J; Lopasso FP; Cordeiro AC; Saez-Alquezar A; Laudanna AA; Pinotti HW
    Hepatogastroenterology; 1996; 43(12):1671-7. PubMed ID: 8975987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
    Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
    Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors.
    Benito-Garcia E; Michaud K; Wolfe F
    J Rheumatol; 2007 Aug; 34(8):1765-9. PubMed ID: 17611980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.